Our recent study (Huang et al, 2008b) found that the aberrant expression of FPR in highly malignant GBM cells is closely associated with increased methylation of the p53 tumour suppressor gene promoter that reduced the capacity of p53 to repress the active transcription of FPR gene. The gene discussed is TP53; the disease is glioblastoma.